Author

Angela M. Schab

Washington University in St. LouisORCID 0000-0003-1569-2452Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Elena LomonosovaiD· 3 shared Mary Margaret MulleniD· 3 shared Andrea R. HagemanniD· 2 shared Brooke E. SandersiD· 2 shared Carmen Sandoval· 2 shared Carolyn Kay McCourtiD· 2 shared David Gardner MutchiD· 2 shared Dineo KhabeleiD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Elena LomonosovaORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BioengineeringbioRxivPreprintMay 12, 2026

3D Printed Bioelectronic Scaffolds for Impedance-based Cytotoxicity Monitoring of In Vitro Cancer Models

Somtochukwu S. Okafor, Sandra K. Montgomery, Jae Park…·Alexandra L. Rutz

This paper introduces 3D printed bioelectronic scaffolds for impedance-based cytotoxicity monitoring in 3D cancer cell cultures, demonstrating their effectiveness in drug response assessment.

DOI 10.64898/2026.05.07.719019

electrophysiologyexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 4, 2025

Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms

Elena Lomonosova, Megan Loeb, Kevin Rodriguez…·Mary Margaret Mullen

The paper identifies COPS5 as a therapeutic target for overcoming platinum resistance in ovarian cancer by inhibiting nucleotide excision repair and interstrand crosslink repair.

DOI 10.1101/2025.08.04.668450

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedMay 20, 2025

Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer

Angela M. Schab, Amanda J. Compadre, Rikki Drexler…·Mary Margaret Mullen

This study identifies phospho-RPA2 as a biomarker predicting response to platinum and PARP inhibitors in HR-proficient ovarian cancer, showing higher pathologic complete response and longer survival in pRPA2-High tumors.

11 citationstop 5%

humanimaging

𝕏 PostBluesky

Molecular BiologyCancer Research CommunicationsPeer-reviewedMar 26, 2024

Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells

Kyle A. Cottrell, Sua Ryu, Jackson R. Pierce…·Jason D. Weber

The paper shows that loss of DHX9 and ADAR1 in breast cancer cells activates dsRNA sensing pathways, leading to a viral mimicry phenotype.

39 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky